Direct-acting vasodilators: Nursing pharmacology

Direct-acting vasodilators: Nursing pharmacology

NSG1201

NSG1201

Leg ulcers: Clinical
Venous thromboembolism (VTE): Nursing process (ADPIE)
Wound healing
Peripheral venous disease (PVD): Nursing process (ADPIE)
Peripheral arterial disease (PAD): Nursing process (ADPIE)
Pharmacodynamics: Nursing pharmacology
Pharmacokinetics - Elimination: Nursing pharmacology
Vital signs - Pain: Nursing skills
Analgesics: Nursing pharmacology
Antacids: Nursing pharmacology
Antibiotics - Cephalosporins: Nursing pharmacology
Antibiotics - Cyclic lipopeptides: Nursing pharmacology
Antibiotics - Glycopeptides: Nursing pharmacology
Antibiotics - Lincosamides: Nursing pharmacology
Antibiotics - Macrolides: Nursing pharmacology
Antibiotics - Metronidazole: Nursing pharmacology
Antibiotics - Oxazolidinones: Nursing pharmacology
Antibiotics - Penicillins: Nursing pharmacology
Antibiotics - Polymyxins: Nursing pharmacology
Antibiotics - Tetracyclines and glycylcyclines: Nursing pharmacology
Antibiotics - Trimethoprim and sulfonamides: Nursing pharmacology
Anticoagulants - Direct thrombin and factor Xa inhibitors: Nursing pharmacology
Anticoagulants - Heparin: Nursing pharmacology
Anticoagulants - Warfarin: Nursing pharmacology
Antidepressants - SSRIs and SNRIs: Nursing pharmacology
Antidepressants - Tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs): Nursing pharmacology
Antiemetics: Nursing pharmacology
Antiepileptics: Nursing pharmacology
Antihistamines: Nursing pharmacology
Antihyperlipidemics - Statins: Nursing pharmacology
Antimetabolites: Nursing pharmacology
Antiplatelet agents: Nursing pharmacology
Antipsychotics: Nursing pharmacology
Antirejection immunosuppressants: Nursing pharmacology
Antiretrovirals for HIV/AIDS - CCR5 antagonists, fusion inhibitors, and attachment inhibitors: Nursing pharmacology
Antiretrovirals for HIV/AIDS - Integrase strand transfer inhibitors: Nursing pharmacology
Antiretrovirals for HIV/AIDS - NRTIs and NNRTIs: Nursing pharmacology
Antiretrovirals for HIV/AIDS - Protease inhibitors: Nursing pharmacology
Antivirals for herpesviruses: Nursing pharmacology
Antivirals for influenza: Nursing pharmacology
Anxiolytics and sedative-hypnotics: Nursing pharmacology
Beta-adrenergic blockers: Nursing pharmacology
Biologic agents: Nursing pharmacology
Blood products: Nursing pharmacology
Calcium-channel blockers: Nursing pharmacology
Cardiac glycosides: Nursing pharmacology
Chloramphenicol: Nursing pharmacology
Debridement agents: Nursing pharmacology
Direct-acting vasodilators: Nursing pharmacology
Disease-modifying therapy for multiple sclerosis: Nursing pharmacology
Diuretics - Osmotic and carbonic anhydrase inhibitors: Nursing pharmacology
Diuretics - Thiazide, thiazide-like, loop, and potassium-sparing diuretics: Nursing pharmacology
Eye anesthetics: Nursing pharmacology
Gallstone-dissolving agents: Nursing pharmacology
Gastric mucosal protective agents: Nursing pharmacology
Glucocorticoids and mineralocorticoids: Nursing pharmacology
Hematopoietic growth factors: Nursing pharmacology
Hemostatics: Nursing pharmacology
Histamine H2 antagonists: Nursing pharmacology
Hormones and hormone modulators for cancer: Nursing pharmacology
Immunoglobulins: Nursing pharmacology
Immunomodulators: Nursing pharmacology
Immunosuppressants for autoimmune diseases: Nursing pharmacology
Corticosteroids - Inhaled: Nursing pharmacology
Insulin: Nursing pharmacology
Iron preparations: Nursing pharmacology
Keratolytics: Nursing pharmacology
Laxatives: Nursing pharmacology
Leukotriene modifiers: Nursing pharmacology
Lung surfactants and antenatal corticosteroids: Nursing pharmacology
Medications affecting the parathyroid glands: Nursing pharmacology
Medications for antidiuretic hormone (ADH) disorders: Nursing pharmacology
Medications for thyroid disorders: Nursing pharmacology
Medications to control airway secretions: Nursing pharmacology
Medications for Alzheimer disease: Nursing pharmacology
Medications for growth hormone disorders: Nursing pharmacology
Medications for acne vulgaris: Nursing pharmacology
Medications for hepatic encephalopathy: Nursing pharmacology
Medications for migraines: Nursing pharmacology
Mydriatics and cycloplegics: Nursing pharmacology
Nitrates: Nursing pharmacology
Non-biologic disease-modifying antirheumatic drug (DMARD) therapy: Nursing pharmacology
Non-insulin injectable antidiabetic drugs - GLP-1 agonists and amylinomimetics: Nursing pharmacology
Ophthalmic anti-inflammatories and anti-infectives: Nursing pharmacology
Oral antidiabetic medications - Alpha-glucosidase inhibitors: Nursing pharmacology
Oral antidiabetic medications - Biguanides and thiazolidinediones: Nursing pharmacology
Oral antidiabetic medications - DPP-4 inhibitors: Nursing pharmacology
Oral antidiabetic medications - Sodium-glucose co-transporter-2 (SGLT-2) inhibitors: Nursing pharmacology
Oral antidiabetic medications - Sulfonylureas and meglitinides: Nursing pharmacology
Other antineoplastics: Nursing pharmacology
Oxygen therapy: Nursing pharmacology
Oxytocin: Nursing pharmacology
Pancreatic enzyme replacements: Nursing pharmacology
Pharmacokinetics - Distribution: Nursing pharmacology
Pharmacokinetics - Metabolism: Nursing pharmacology
Phytonadione (Vitamin K1): Nursing pharmacology
Plant extracts for chemotherapy: Nursing pharmacology
Platinum-based agents: Nursing pharmacology
Prostaglandins: Nursing pharmacology
Proton pump inhibitors (PPIs): Nursing pharmacology
Respiratory stimulants: Nursing pharmacology
Rho(D) immune globulin: Nursing pharmacology
Sympathomimetic medications: Nursing pharmacology
Thrombolytics: Nursing pharmacology
Tocolytics: Nursing pharmacology
Antibiotics - Topical: Nursing pharmacology
Antifungals - Topical: Nursing pharmacology
Corticosteroids - Topical: Nursing pharmacology
Treatment for Helicobacter pylori: Nursing pharmacology
Antispasmodics (GU): Nursing pharmacology
Cholinergic therapy (GU): Nursing pharmacology
Vaccines: Nursing pharmacology
Pharmacokinetics - Absorption: Nursing pharmacology
Pressure injury: Nursing process (ADPIE)
Emergency care: Falls
Diabetic ketoacidosis (DKA): Nursing process (ADPIE)
Inflammatory process: Nursing
Nutrition - Oral: Nursing skills
Core measures: Nursing
Standards and methods of documentation: Nursing
Physical assessment - Abdomen: Nursing
Physical assessment - Overview: Nursing
Vital signs - Blood pressure (BP): Nursing skills
Vital signs - Oxygen saturation (SpO2): Nursing skills
Vital signs - Respirations: Nursing skills
Vital signs - Pulse: Nursing skills
Vital Signs - Temperature: Nursing skills
Comprehensive Assessment
Mobility - Ambulation: Nursing skills

Notes

DIRECT-ACTING VASODILATORS
DRUG NAME
hydralazine (Apresoline), minoxidil (Loniten), 
sodium nitroprusside (Nipride, Nitropress) 
*High Alert Medication*
CLASS
Direct-acting vasodilators
MECHANISM OF ACTION
Prevent the increase of intracellular calcium concentration within vascular smooth muscle cells → vasodilation → reduced total peripheral resistance and blood pressure
INDICATIONS
  • Severe refractory hypertension
  • Malignant hypertension
  • Hypertensive emergencies
ROUTE(S) OF ADMINISTRATION
  • Hydralazine: PO, IV, IM
  • Minoxidil: PO
  • Sodium nitroprusside: IV
SIDE EFFECTS
  • Hypotension
  • Dizziness
  • Headache
  • Reflex tachycardia
  • Palpitations
  • Edema
  • Nausea
  • Vomiting
  • GI distress
  • Minoxidil: pericardial effusion (boxed warning), cardiac tamponade
  • Nitroprusside: Cyanide poisoning (boxed warning), hypothyroidism
CONTRAINDICATIONS AND CAUTIONS
  • Cerebrovascular insufficiency
  • Peripheral vascular disease
  • Coronary artery disease
  • Heart failure
  • Mitral valve disease
  • Pregnancy and breastfeeding
  • Septic shock
NURSING CONSIDERATIONS: DIRECT-ACTING VASODILATORS
ASSESSMENT AND MONITORING
Baseline assessment
  • Vital signs, ECG, heart and lung sounds, weight, CBC, electrolytes, hepatic and renal function

Hydralazine IV
  • Patent IV access
  • Frequent vital signs; signs of fluid overload - edema, pulmonary crackles, orthopnea

Nitroprusside IV
  • Continuous cardiorespiratory monitoring
  • Automatic blood pressure monitoring
  • Patent IV access
  • Emergency equipment and sodium thiosulfate readily available
  • Double-check infusion pump settings with a second nurse
  • Monitor for extravasation
  • Assess for signs of toxicity: altered mental status, agitation, tremor
  • For suspected toxicity, stop the infusion and notify the physician immediately; prepare to administer antidote
CLIENT EDUCATION
  • Concurrent use of beta-blocker and diuretic
  • Report signs of water retention, shortness of breath, fast heart beat (reflex tachycardia), chest pain

Hydralazine
  • Take with meals
  • Report side effects: symptoms of lupus-like syndrome: muscle aches, joint pain, fever

Minoxidil
  • Take without regard to meals
  • Can cause reversible increase in hair growth

Nitroprusside
  • Report burning or stinging at IV site, tinnitus
Author: Victoria S. Recalde, MD
Illustrator: Robyn Hughes, MScBMC

Transcript

Watch video only

Direct-acting vasodilators are a class of antihypertensive medications that are used for severe refractory hypertension, malignant hypertension, and hypertensive emergencies. These medications include hydralazine, which can be administered orally, intravenously, and intramuscularly; minoxidil, which can be administered orally or topically; and sodium nitroprusside, which is given intravenously.

Once administered, direct acting vasodilators rapidly work on the vascular smooth muscle cells by preventing the increase of intracellular calcium concentration.

As a result, direct acting vasodilators prevent vasoconstriction and promote vasodilation, leading to a reduction in the total peripheral resistance and blood pressure.

Keep in mind that hydralazine and minoxidil mainly work on arterioles, while sodium nitroprusside works on both arterioles and venules.

Now, since direct acting vasodilators tend to work rapidly, they can result in sudden vasodilation and hypotension. This may lead to side effects, including dizziness, headache, reflex tachycardia, palpitations, and edema.

Other side effects include nausea, vomiting, and gastrointestinal distress. So to counteract side effects like reflex tachycardia and edema, direct acting vasodilators can be used in combination with beta-blockers or diuretics, but under close monitoring for adverse effects.

Now, through an unclear mechanism, hydralazine may trigger a lupus-like syndrome, which can involve multiple organs. Clients may experience severe malaise, myalgia, arthralgia, pericarditis, and hepatosplenomegaly, and upon blood tests, they may present with leukopenia, thrombocytopenia, and positive autoantibodies.

What’s important to keep in mind is that hydralazine-induced lupus-like syndrome mainly affects clients who take higher doses for a prolonged period of time, and can be reversed upon discontinuation of hydralazine.

Regarding minoxidil, an important boxed warning is that it can cause pericardial effusion, which may progress to cardiac tamponade, and it can exacerbate angina pectoris.

On that account, minoxidil should be reserved for hypertensive clients who don’t respond adequately to the maximum therapeutic doses of two other antihypertensive medications and a diuretic.

Another interesting side effect of minoxidil is hypertrichosis, which means excessive hair growth! In fact, minoxidil can be applied topically to promote hair growth and treat hair loss or alopecia.

Finally, sodium nitroprusside has a boxed warning because it contains cyanide, which is released when nitroprusside is metabolized; normally the liver is able to convert the cyanide into a less toxic byproduct called thiocyanate, but if nitroprusside is given over several days, the cyanide can accumulate and cause problems such as disorientation and delirium.

Moreover, if sodium nitroprusside is administered too quickly, clients may develop cyanide poisoning, which can lead to hypoxia and metabolic acidosis.

Cyanide poisoning typically presents with dizziness, confusion, headache, mydriasis, tachypnea, and tachycardia; while severe cases can develop hypotension, apnea, seizures, and even coma.

Finally, sodium nitroprusside can also suppress iodine uptake by thyroid cells, which can lead to hypothyroidism.

Direct-acting vasodilators are contraindicated in clients with cerebrovascular insufficiency and any other condition that could be worsened by a sudden decrease in blood pressure, like peripheral vascular disease, coronary artery disease, heart failure, and mitral valve disease, as well as septic shock.

Sources

  1. "Karch’s Focus on Nursing Pharmacology, 9th edition" LWW (2023)
  2. "Pharmacology: A Patient-Centered Nursing Process Approach, 9th edition" Elsevier Canada (2020)
  3. "Mosby’s 2023 Nursing Drug Reference, 36th edition" Mosby (2022)
  4. "Saunders Comprehensive Review for the NCLEX-RN, 9th Edition" Saunders (2022)
  5. "Impact of Platelet Reactivity in ACS Patients on Clinical Outcomes with Triple Antithrombotic Therapy" Journal of Clinical Medicine (2021)
  6. "Severe Bradycardia Induced by Sofosbuvir and Amiodarone which Resolved after the Discontinuation of Both Drugs" Intern Med (2020)
  7. "Nigella Sativa (Black Seeds), A Potential Herb for the Pharmacotherapeutic Management of Hypertension - A Review" Curr Cardiol Rev (2021)